🇧🇷 Jemperli in Brazil

Jemperli (DOSTARLIMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Jemperli in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Jemperli approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Jemperli in Brazil?

GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.